Disease: Rufous oculocutaneous albinism
- An ultrastructural study of melanocytes and melanosomes in the skin and hair bulbs of rufous albinos
- Complex interactions of Tyrp1 in the eye
- DeoxyArbutin and its derivatives inhibit tyrosinase activity and melanin synthesis without inducing reactive oxygen species or apoptosis
- In silico screening and molecular dynamics simulation of disease-associated nsSNP in TYRP1 gene and its structural consequences in OCA3
- In vitro characterization of the intramelanosomal domain of human recombinant TYRP1 and its oculocutaneous albinism type 3-related mutant variants
- Minimal Efficacy of Nitisinone Treatment in a Novel Mouse Model of Oculocutaneous Albinism, Type 3
- Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4
- Mutations in the MATP gene in five German patients affected by oculocutaneous albinism type 4
- Oculocutaneous albinism type 3 (OCA3): analysis of two novel mutations in TYRP1 gene in two Chinese patients
- Oculocutaneous albinism type 3: a Japanese girl with novel mutations in TYRP1 gene
- Oculocutaneous albinism with TYRP1 gene mutations in a Caucasian patient
- Red or rufous albinism in southern Africa
- Rufous albinism
- Rufous oculocutaneous albinism in southern African Blacks is caused by mutations in the TYRP1 gene
- TYPES OF ALBINISM IN THE BLACK SOUTHERN AFRICA POPULATION
- Tyrp1 Mutant Variants Associated with OCA3: Computational Characterization of Protein Stability and Ligand Binding
